Morgan Stanley’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-9,554
| Closed | -$14K | – | 8305 |
|
|
2022
Q1 | $14K | Sell |
9,554
-9,000
| -49% | -$13.2K | ﹤0.01% | 7300 |
|
|
2021
Q4 | $43K | Sell |
18,554
-14,994
| -45% | -$34.7K | ﹤0.01% | 6890 |
|
|
2021
Q3 | $184K | Sell |
33,548
-2,978
| -8% | -$16.3K | ﹤0.01% | 6048 |
|
|
2021
Q2 | $272K | Buy |
36,526
+16,864
| +86% | +$126K | ﹤0.01% | 5862 |
|
|
2021
Q1 | $159K | Sell |
19,662
-2,689
| -12% | -$21.7K | ﹤0.01% | 5787 |
|
|
2020
Q4 | $203K | Buy |
22,351
+11,975
| +115% | +$109K | ﹤0.01% | 5584 |
|
|
2020
Q3 | $115K | Sell |
10,376
-6,095
| -37% | -$67.6K | ﹤0.01% | 5362 |
|
|
2020
Q2 | $122K | Buy |
16,471
+3,772
| +30% | +$27.9K | ﹤0.01% | 5312 |
|
|
2020
Q1 | $78K | Sell |
12,699
-12,414
| -49% | -$76.2K | ﹤0.01% | 5291 |
|
|
2019
Q4 | $127K | Buy |
25,113
+18,605
| +286% | +$94.1K | ﹤0.01% | 5578 |
|
|
2019
Q3 | $49K | Buy |
6,508
+4,199
| +182% | +$31.6K | ﹤0.01% | 5736 |
|
|
2019
Q2 | $27K | Buy |
2,309
+199
| +9% | +$2.33K | ﹤0.01% | 5836 |
|
|
2019
Q1 | $31K | Buy |
+2,110
| New | +$31K | ﹤0.01% | 5874 |
|